Delay in Seeking Medical Help in Patients with New-Onset Erectile Dysfunction Remained High Over and Despite the PDE5 Era-An Ecological Study

Andrea Salonia, Matteo Ferrari, Antonino Saccà, Federico Pellucchi, Giulia Castagna, Maria Chiara Clementi, Rayan Matloob, Alberto Briganti, Patrizio Rigatti, Francesco Montorsi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Introduction: It is common knowledge among researchers that erectile dysfunction (ED) is an important sentinel marker of cardiovascular and overall men's health. Aim: Determine whether the delay of time between ED onset and seeking medical help (DSH), considered as a proxy of awareness of the importance of ED for overall men's health, has shortened during the phosphodiesterase type 5 inhibitors (PDE5) era. Methods: Complete data from 619 patients seeking first medical help for new-onset ED as their primary disorder between July 2000 and July 2010 were analyzed (i.e., DSH, ED severity as defined by the International Index of Erectile Function-erectile function [IIEF-EF] domain score, patient's awareness of any PDE5, and Charlson Comorbidity Index [CCI]). Analysis of variance tested DSH throughout the 10-year time frame. Cox regression models tested the association between predictors and DSH. Main Outcome Measures: Assess if DSH has shortened throughout PDE5 era. Evaluate potential predictors of DSH. Results: Overall, mean DSH was 30.2 months (median 12.0; range 5-300 months). DSH shortened throughout the analyzed 10-year period (F=1.918; P=0.047), with a significant drop only from year 2009 (DSH up to year 2008 vs. from year 2009: 31.0 months [12.0] vs. 7.5 months [6.0], respectively; P

Original languageEnglish
Pages (from-to)3239-3246
Number of pages8
JournalJournal of Sexual Medicine
Volume9
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Phosphodiesterase 5 Inhibitors
Erectile Dysfunction
Men's Health
Proxy
Proportional Hazards Models
Comorbidity
Analysis of Variance
Research Personnel
Outcome Assessment (Health Care)

Keywords

  • Awareness
  • Erectile dysfunction
  • Phosphodiesterase type 5 inhibitors
  • Sildenafil
  • Tadalafil
  • Vardenafil

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Delay in Seeking Medical Help in Patients with New-Onset Erectile Dysfunction Remained High Over and Despite the PDE5 Era-An Ecological Study. / Salonia, Andrea; Ferrari, Matteo; Saccà, Antonino; Pellucchi, Federico; Castagna, Giulia; Clementi, Maria Chiara; Matloob, Rayan; Briganti, Alberto; Rigatti, Patrizio; Montorsi, Francesco.

In: Journal of Sexual Medicine, Vol. 9, No. 12, 12.2012, p. 3239-3246.

Research output: Contribution to journalArticle

Salonia, Andrea ; Ferrari, Matteo ; Saccà, Antonino ; Pellucchi, Federico ; Castagna, Giulia ; Clementi, Maria Chiara ; Matloob, Rayan ; Briganti, Alberto ; Rigatti, Patrizio ; Montorsi, Francesco. / Delay in Seeking Medical Help in Patients with New-Onset Erectile Dysfunction Remained High Over and Despite the PDE5 Era-An Ecological Study. In: Journal of Sexual Medicine. 2012 ; Vol. 9, No. 12. pp. 3239-3246.
@article{fa8bbf3e275542dca686c1c92216bda8,
title = "Delay in Seeking Medical Help in Patients with New-Onset Erectile Dysfunction Remained High Over and Despite the PDE5 Era-An Ecological Study",
abstract = "Introduction: It is common knowledge among researchers that erectile dysfunction (ED) is an important sentinel marker of cardiovascular and overall men's health. Aim: Determine whether the delay of time between ED onset and seeking medical help (DSH), considered as a proxy of awareness of the importance of ED for overall men's health, has shortened during the phosphodiesterase type 5 inhibitors (PDE5) era. Methods: Complete data from 619 patients seeking first medical help for new-onset ED as their primary disorder between July 2000 and July 2010 were analyzed (i.e., DSH, ED severity as defined by the International Index of Erectile Function-erectile function [IIEF-EF] domain score, patient's awareness of any PDE5, and Charlson Comorbidity Index [CCI]). Analysis of variance tested DSH throughout the 10-year time frame. Cox regression models tested the association between predictors and DSH. Main Outcome Measures: Assess if DSH has shortened throughout PDE5 era. Evaluate potential predictors of DSH. Results: Overall, mean DSH was 30.2 months (median 12.0; range 5-300 months). DSH shortened throughout the analyzed 10-year period (F=1.918; P=0.047), with a significant drop only from year 2009 (DSH up to year 2008 vs. from year 2009: 31.0 months [12.0] vs. 7.5 months [6.0], respectively; P",
keywords = "Awareness, Erectile dysfunction, Phosphodiesterase type 5 inhibitors, Sildenafil, Tadalafil, Vardenafil",
author = "Andrea Salonia and Matteo Ferrari and Antonino Sacc{\`a} and Federico Pellucchi and Giulia Castagna and Clementi, {Maria Chiara} and Rayan Matloob and Alberto Briganti and Patrizio Rigatti and Francesco Montorsi",
year = "2012",
month = "12",
doi = "10.1111/j.1743-6109.2012.02953.x",
language = "English",
volume = "9",
pages = "3239--3246",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Delay in Seeking Medical Help in Patients with New-Onset Erectile Dysfunction Remained High Over and Despite the PDE5 Era-An Ecological Study

AU - Salonia, Andrea

AU - Ferrari, Matteo

AU - Saccà, Antonino

AU - Pellucchi, Federico

AU - Castagna, Giulia

AU - Clementi, Maria Chiara

AU - Matloob, Rayan

AU - Briganti, Alberto

AU - Rigatti, Patrizio

AU - Montorsi, Francesco

PY - 2012/12

Y1 - 2012/12

N2 - Introduction: It is common knowledge among researchers that erectile dysfunction (ED) is an important sentinel marker of cardiovascular and overall men's health. Aim: Determine whether the delay of time between ED onset and seeking medical help (DSH), considered as a proxy of awareness of the importance of ED for overall men's health, has shortened during the phosphodiesterase type 5 inhibitors (PDE5) era. Methods: Complete data from 619 patients seeking first medical help for new-onset ED as their primary disorder between July 2000 and July 2010 were analyzed (i.e., DSH, ED severity as defined by the International Index of Erectile Function-erectile function [IIEF-EF] domain score, patient's awareness of any PDE5, and Charlson Comorbidity Index [CCI]). Analysis of variance tested DSH throughout the 10-year time frame. Cox regression models tested the association between predictors and DSH. Main Outcome Measures: Assess if DSH has shortened throughout PDE5 era. Evaluate potential predictors of DSH. Results: Overall, mean DSH was 30.2 months (median 12.0; range 5-300 months). DSH shortened throughout the analyzed 10-year period (F=1.918; P=0.047), with a significant drop only from year 2009 (DSH up to year 2008 vs. from year 2009: 31.0 months [12.0] vs. 7.5 months [6.0], respectively; P

AB - Introduction: It is common knowledge among researchers that erectile dysfunction (ED) is an important sentinel marker of cardiovascular and overall men's health. Aim: Determine whether the delay of time between ED onset and seeking medical help (DSH), considered as a proxy of awareness of the importance of ED for overall men's health, has shortened during the phosphodiesterase type 5 inhibitors (PDE5) era. Methods: Complete data from 619 patients seeking first medical help for new-onset ED as their primary disorder between July 2000 and July 2010 were analyzed (i.e., DSH, ED severity as defined by the International Index of Erectile Function-erectile function [IIEF-EF] domain score, patient's awareness of any PDE5, and Charlson Comorbidity Index [CCI]). Analysis of variance tested DSH throughout the 10-year time frame. Cox regression models tested the association between predictors and DSH. Main Outcome Measures: Assess if DSH has shortened throughout PDE5 era. Evaluate potential predictors of DSH. Results: Overall, mean DSH was 30.2 months (median 12.0; range 5-300 months). DSH shortened throughout the analyzed 10-year period (F=1.918; P=0.047), with a significant drop only from year 2009 (DSH up to year 2008 vs. from year 2009: 31.0 months [12.0] vs. 7.5 months [6.0], respectively; P

KW - Awareness

KW - Erectile dysfunction

KW - Phosphodiesterase type 5 inhibitors

KW - Sildenafil

KW - Tadalafil

KW - Vardenafil

UR - http://www.scopus.com/inward/record.url?scp=84870603492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870603492&partnerID=8YFLogxK

U2 - 10.1111/j.1743-6109.2012.02953.x

DO - 10.1111/j.1743-6109.2012.02953.x

M3 - Article

C2 - 23057479

AN - SCOPUS:84870603492

VL - 9

SP - 3239

EP - 3246

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 12

ER -